MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
February 24, 2010
Brian Orelli
Medtronic Needs to Regrow a Spine Everything else looks fairly good, but the problem I see involves the slight decline in Medtronic's second-largest segment, spinal products. mark for My Articles similar articles
The Motley Fool
August 20, 2008
Brian Orelli
Medtronic Muddles Through The medical device maker manages double-digit growth in a tough market. mark for My Articles similar articles
The Motley Fool
August 25, 2009
Brian Orelli
Medtronic Takes the Road Less Traveled It looks like this medical devices company is healthy again. mark for My Articles similar articles
The Motley Fool
August 24, 2011
Brian Orelli
Growth, but Not Great Growth Medtronic's growth comes with lower margins. mark for My Articles similar articles
The Motley Fool
August 24, 2010
Brian Orelli
Disaster in Medical-Device Land Industry bellwether Medtronic is forecasting a nasty storm. mark for My Articles similar articles
The Motley Fool
February 20, 2008
Brian Orelli
Medtronic Looks Ahead After a rough second half of last year, Medtronic is leaving its problems behind, and optimistically focusing on the future. mark for My Articles similar articles
The Motley Fool
August 22, 2007
Ryan Fuhrmann
Upbeat About Medtronic The future looks bright at medical-device firm Medtronic, and the stock price is reasonable. First quarter sales grew, as overseas revenue improved an impressive 16%. mark for My Articles similar articles
The Motley Fool
August 18, 2005
Stephen D. Simpson
Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay. mark for My Articles similar articles
The Motley Fool
February 3, 2011
Brian Orelli
Add This Stock to Your Show-Me List Wait for the turnaround before investing in Boston Scientific; if it ever comes. mark for My Articles similar articles
The Motley Fool
May 25, 2011
Brian Orelli
No Red Carpet for Medtronic's New CEO Omar Ishrak, Medtronic's newly-appointed CEO, looks like he has his work cut out for him trying to get the medical-device maker growing again. mark for My Articles similar articles
The Motley Fool
February 17, 2009
Brian Orelli
Investors Heart Medtronic The leaner company is more lovable. mark for My Articles similar articles
The Motley Fool
August 31, 2011
Harsh Chauhan
Medtronic Looks Set for Takeoff Medtronic shares jump after flat quarterly growth as it looks toward global expansion. mark for My Articles similar articles
The Motley Fool
February 17, 2005
Stephen D. Simpson
Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock? mark for My Articles similar articles
The Motley Fool
November 21, 2007
Rich Smith
Medtronic Motors Ahead Shares of the medical equipment maker soared yesterday and continue to buck the downtrend on Wall Street, in the wake of a fiscal Q2 2008 earnings report that exceeded expectations for both sales and profits. mark for My Articles similar articles
The Motley Fool
January 6, 2005
Stephen D. Simpson
Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past. mark for My Articles similar articles
The Motley Fool
August 18, 2008
Brian Orelli
Foolish Forecast: Taking Medtronic to Heart In advance of earnings analysts expect Medtronic, with another medical device approval, to boost revenues 17%. mark for My Articles similar articles
The Motley Fool
November 24, 2009
Brian Orelli
52-Week Highs! What's Going On? Even with its recent leap, this stock may belong in your portfolio. Medtronic raised earnings guidance today after a fairly strong quarter, and the stock is hitting new 52-week highs. mark for My Articles similar articles
The Motley Fool
May 26, 2005
Stephen D. Simpson
A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges? mark for My Articles similar articles
The Motley Fool
May 25, 2010
Brian Orelli
Medtronic Gets Tossed Out With the Bathwater A bad day to report good news. mark for My Articles similar articles
The Motley Fool
April 21, 2009
Brian Orelli
Boston Scientific Rebuilds Whether the company is a value or a value trap depends on how well the rebuilding goes this year. mark for My Articles similar articles
The Motley Fool
November 21, 2006
Ryan Fuhrmann
Shocking Results at Medtronic Favorable earnings boost shares of this medical equipment maker -- but are they too high already? mark for My Articles similar articles
The Motley Fool
April 27, 2010
Brian Orelli
Boston Scientific's "Challenging" Quarter Boston Scientific fixed its paperwork problem with the Food and Drug Administration earlier this month, but the resulting recall took its toll on first-quarter profits nonetheless. mark for My Articles similar articles
The Motley Fool
May 24, 2007
Ryan Fuhrmann
Chronic Healthiness at Medtronic The med-tech firm isn't growing as fast as it once was, but its fourth-quarter earnings report still managed to beat Wall Street's expectations. mark for My Articles similar articles
The Motley Fool
November 18, 2008
Brian Orelli
No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy. mark for My Articles similar articles
The Motley Fool
November 18, 2004
W.D. Crotty
Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy. mark for My Articles similar articles
The Motley Fool
April 19, 2007
Billy Fisher
A Saintly Quarter Shares of St. Jude Medical rise after the company announces a big quarter. mark for My Articles similar articles
The Motley Fool
May 21, 2008
Brian Orelli
Medtronic's Endeavors Look Good The medical device maker's new drug-eluting stent helps push up revenue. mark for My Articles similar articles
The Motley Fool
October 20, 2006
Ryan Fuhrmann
Boston's Unscientific Results Boston Scientific reported third-quarter results that were at the upper end of the company's late-September earnings warning. The shares have had a rough run lately, down nearly 40% over the past year. Buying opportunity? mark for My Articles similar articles
The Motley Fool
February 22, 2006
Stephen D. Simpson
Medtronic's Minor Miss Sluggish sales in several market categories might spook investors. mark for My Articles similar articles
The Motley Fool
July 29, 2011
Brian Orelli
Boston Scientific Shows Me The company has shown it can hit its mark for at least one quarter, but can it last? mark for My Articles similar articles
The Motley Fool
October 16, 2007
Billy Fisher
A Heartbreaker at Medtronic The medical device maker halts distribution of certain defibrillator wires. Shares of Medtronic are now very close to the stock's 52-week low. mark for My Articles similar articles
The Motley Fool
March 29, 2011
Brian Orelli
Medtronic's Exciting New Toys The device maker received multiple approvals in less than a week. mark for My Articles similar articles
The Motley Fool
May 24, 2006
Stephen D. Simpson
Measuring Up Medtronic Everyone loves the med-tech firm. That makes it a dangerous investment. mark for My Articles similar articles
The Motley Fool
May 19, 2009
Brian Orelli
Medtronic Gets Whacked, Seeks Recovery Device Medtronic gets hammered on lackluster guidance. mark for My Articles similar articles
The Motley Fool
November 15, 2007
Rich Smith
Foolish Forecast: Mulling Medtronic In advance of earnings reports, analysts expect sales from the medical-equipment maker to remain flat and profit to fall slightly. mark for My Articles similar articles
The Motley Fool
February 5, 2008
Brian Orelli
Boston Scientific Gets Charged Walloped by charges, Boston Scientific posts a loss for the quarter. mark for My Articles similar articles
The Motley Fool
February 24, 2009
Brian Orelli
Medtronic Hearts Acquisitions Medical device maker Medtronic pays a little over $1 billion for two acquisitions in one day. mark for My Articles similar articles
The Motley Fool
July 25, 2006
Ryan Fuhrmann
A Steady Heartbeat at Edwards Can Edwards Lifesciences grow enough to justify its stock price? mark for My Articles similar articles
The Motley Fool
February 12, 2004
Jeff Hwang
Rockin' Medtronic The world's premier medical device maker keeps on growing. mark for My Articles similar articles
The Motley Fool
July 21, 2010
Brian Orelli
Boston Scientific Bounces When you're as beaten-down as Boston Scientific, you seemingly have nowhere to go but up. There's also bankruptcy, but the beleaguered medical device maker seems far from that -- at least for now. mark for My Articles similar articles
The Motley Fool
July 18, 2008
Brian Orelli
St. Jude Is a Fighter The medical device maker continues to kick the competition while it's down. mark for My Articles similar articles
The Motley Fool
October 20, 2009
Robert Steyer
The Heart Company's Disheartening Forecast Boston Scientific scaled back its full-year forecast, and the market doesn't like it. mark for My Articles similar articles
The Motley Fool
July 19, 2006
Stephen D. Simpson
Taking St. Jude's Pulse The ICD market is a long-term opportunity, but not a panacea. St. Jude investors should remember that this is a rough neighborhood -- product liability, FDA bureaucracy, and huge, tough competitors live here, too. mark for My Articles similar articles
The Motley Fool
June 4, 2010
Jim Mueller
The Changing Face of Abbott Abbott Labs' shift in revenue sources has been a boon over the last five years. mark for My Articles similar articles
The Motley Fool
April 22, 2010
Brian Orelli
Abbott's Stuck in a Double-Digit Rut The company keeps cranking out solid earnings, but investors don't seem to care. mark for My Articles similar articles
The Motley Fool
February 26, 2008
Brian Orelli
Quick Take: Boston Scientific Gets Approved -- Thrice The medical device maker is granted three FDA approvals in one day. mark for My Articles similar articles
The Motley Fool
September 14, 2011
Brian Orelli
How to Muck Up a Turnaround in 12 and a Half Months Boston Scientific's choice for a new CEO has the potential to really muck up its recovery even further -- if that's even possible. mark for My Articles similar articles
The Motley Fool
May 20, 2009
Brian Orelli
Joining to Treat, and Beat, Diabetes Medical-device maker Medtronic and drugmaker Eli Lilly are teaming up to co-promote the companies' diabetes products to doctors and patients. mark for My Articles similar articles
The Motley Fool
June 30, 2011
Brian Orelli
Medical-Device Makers' Killer: Health-Care Inflation High prices have painted their targets. mark for My Articles similar articles
The Motley Fool
July 23, 2008
Brian Orelli
Leaner Boston Scientific Isn't Looking Healthy Investors are rightfully growing weary of Boston Scientific's ability to cut expenses on flat sales, and they send the stock down. mark for My Articles similar articles